Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bocchetta

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Psychopharmacology|April 1, 1997
Carbamazepine augmentation in lithium-refractory bipolar patients: a prospective study on long-term prophlyactic effectivenessA Bocchetta, C Chillotti, G Severino, et al.
Progress in Brain Research|January 1, 1986
Dopamine agonists in the treatment of schizophreniaM Del Zompo, A Bocchetta, M P Piccardi, et al.
Psychiatric Genetics|July 21, 1999
Maternal inheritance of manic depression in hemizygotes for the G6PD-Mediterranean mutation. Indirect evidence for Xq28 transmission in SardiniaA Bocchetta, M P Piccardi, V Martinelli, et al.
Acta Psychiatrica Scandinavica|July 5, 2001
Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patientsA Bocchetta, C Chillotti, G Carboni, et al.
Biochemical Pharmacology|December 15, 1984
Inhibition of [3H] MPTP binding to rat brain by pargylineM Del Zompo, A Bocchetta, M P Piccardi, et al.
Journal of Neural Transmission. Supplementum|January 1, 1986
Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitroG U Corsini, S Pintus, A Bocchetta, et al.
Neuropharmacology|December 1, 1981
The use of dopamine agonists in the treatment of schizophreniaG U Corsini, G F Pitzalis, F Bernardi, et al.
Advances in Neurology|January 1, 1987
Characterization of [3H]MPTP binding sitesG U Corsini, S Pintus, A Bocchetta, et al.
Biochemical Pharmacology|November 1, 1988
Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivoG U Corsini, A Bocchetta, A Zuddas, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidaseG U Corsini, S Pintus, A Bocchetta, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Psychopharmacology|April 1, 1997
Carbamazepine augmentation in lithium-refractory bipolar patients: a prospective study on long-term prophlyactic effectivenessA Bocchetta, C Chillotti, G Severino, et al.
Progress in Brain Research|January 1, 1986
Dopamine agonists in the treatment of schizophreniaM Del Zompo, A Bocchetta, M P Piccardi, et al.
Psychiatric Genetics|July 21, 1999
Maternal inheritance of manic depression in hemizygotes for the G6PD-Mediterranean mutation. Indirect evidence for Xq28 transmission in SardiniaA Bocchetta, M P Piccardi, V Martinelli, et al.
Acta Psychiatrica Scandinavica|July 5, 2001
Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patientsA Bocchetta, C Chillotti, G Carboni, et al.
Biochemical Pharmacology|December 15, 1984
Inhibition of [3H] MPTP binding to rat brain by pargylineM Del Zompo, A Bocchetta, M P Piccardi, et al.
Journal of Neural Transmission. Supplementum|January 1, 1986
Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitroG U Corsini, S Pintus, A Bocchetta, et al.
Neuropharmacology|December 1, 1981
The use of dopamine agonists in the treatment of schizophreniaG U Corsini, G F Pitzalis, F Bernardi, et al.
Advances in Neurology|January 1, 1987
Characterization of [3H]MPTP binding sitesG U Corsini, S Pintus, A Bocchetta, et al.
Biochemical Pharmacology|November 1, 1988
Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivoG U Corsini, A Bocchetta, A Zuddas, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidaseG U Corsini, S Pintus, A Bocchetta, et al.
Pageof 4